Combinatorial synthesis of (E)-b-trifluoromethyl vinylsulfones is accomplished through a reaction of alkynes, Togni reagent, and sodium benzenesulfinates in DMSO under metal-free conditions at room temperature. These compounds are evaluated in several assays against different tumor cells. Some hits are identified against ES-2, HO-8910, and K562.
Introduction
The chalcogen-containing skeleton has become a privileged and attractive scaffold in medicinal chemistry owing to its unique biological activities. 1 In particular, more and more novel biological effects of vinyl sulfone compounds have been discovered recently. It has been reported that structures containing an a,bunsaturated vinylsulfone moiety exhibit modest inhibitory potencies in inammation as a novel class toward Parkinson's 2, 3 and arthritis 4 disease therapy by depressing the expression of endothelial cells of adhesion molecules, including vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), as well as inhibiting the nuclear factor E2related factor 2 (Nrf2) pathway which is responsible for the cellular defense system against oxidative stress. They also possess other biological activities, such as anti-Gram-positive bacteria as SrtA transpeptidase inhibitors, 5 anti-parasitic as cysteine protease inhibitors, 6 and anti-virus as potent inhibitors of HIV-1 integrase. 7 Since compounds with substitution of uorine might have a higher stability against metabolic enzymes and a better membranous permeability, 8, 9 we therefore considered to introduce a trans-triuoromethyl group to the a,b-unsaturated vinylsulfone entity (Scheme 1). Thus, we initiated a program for the combinatorial synthesis of triuoromethyl-substituted (E)vinylsulfones and their biological evaluations as antitumor agents. Recently, we and others have involved in the synthesis of sulfonyl compounds, 10, 11 and we identied that (E)-b-tri-uoromethyl vinylsulfones could be accessed through a threecomponent reaction of alkynes, Togni reagent, and sodium benzenesulnates in DMSO under metal-free conditions at room temperature. 12 We envisioned that the library of (E)-b-triuoromethyl vinylsulfones could be constructed via this method through diversity-oriented synthesis.
Herein, we report the biological evaluation of a series of trans-triuoromethyl vinylsulfone derivatives by aim to study the structure-activity relationship and identify a hit structure. By initial screening, we found that the introduction of b-trans-triuoromethyl group led to a potent activity against tumor cells proliferation.
Results and discussion

Chemistry
The synthetic route for the target (E)-b-triuoromethyl vinylsulfones was described in Scheme 2. 12 By treatment of alkynes 1, Scheme 1 Generation of (E)-b-trifluoromethyl vinylsulfones.
Scheme 2 Synthesis of (E)-b-trifluoromethyl vinylsulfones. Togni reagent, and sodium benzenesulnates 2 in DMSO under metal-free conditions at room temperature, a series of (E)-b-triuoromethyl vinylsulfones 3 were obtained in moderate to good yields. On the basis of this strategy, the library of (E)-b-triuoromethyl vinylsulfones was constructed easily with high efficiency.
Biological activity
We chose (E)-(3,3,3-triuoro-1-(phenylsulfonyl)prop-1-en-1-yl) benzene as our structural template and modied the aryl groups. Subsequently, 15 derivatives were synthesized, which included various functional groups on both aryl groups (Ar 1 and Ar 2 ) (Table 1, compounds 3-1 to 3-15). To our delight, these compounds had an excellent inhibitory activity against different tumor cells and especially against ES-2, HO-8910 and K562 with less than 10 mM of IC 50 values. As outlined in Table 1 , it was apparent that compounds 3-1 to 3-4 offered reasonable potency proles when the electron-withdrawing groups were introduced to Ar 1 , while the electron-donating groups on Ar 1 (compounds 3-5 and 6) would result in decreased activities. But the much stronger electron-withdrawing groups of cyano, uoro, and tri-uoromethyl didn't give better activity improvements (compounds 3-4, 3-7 to 3-9, and 3-11). A same electronic effect was also found on Ar 2 (compounds 3-16 to 3-20), but the activity changes were much minor than that on Ar 1 . To further validate the activities of electron-withdrawing groups, more substituents were introduced to investigate the structure-activity relations ( Table 2 , compounds 3-16 to 3-30). With the same results, the changes of Ar 2 didn't make signicant activity changes (compounds 3-16 to [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Compound 3-27, with an acetyl group on p-position of Ar 1 , all of the IC 50 values on ES-2, HO-8910, A2780, and K562 decreased to nM level. However, the compound became more inactive when the acetyl group was connected on the m-position (compound 3-28). When the acetyl group was attached on Ar 2 , the activity was affected very little (compounds 3-20, 21, 23, and 25). Interestingly, when a strong electron-withdrawing carboxyl group was introduced to Ar 1 (compounds 3-25 and 3-26), the activity was dramatically decreased. Therefore, it was reasonable to conclude that an acetyl group on the p-position of Ar 1 was essential for the inhibitory activity, which might be due to a better noncovalent binding to the biological target by a moderate electronic withdrawing effect of the acetyl group.
Moreover, we synthesized compounds without double bond or triuoromethyl group to identify the key structure of this skeleton (compounds 3-29 and 30). The results showed that the proliferation inhibition activities of these two compounds were both obviously inhibited compared with 3-27, about 40-, 11-, and 43-fold decrease for 3-29, and 60-, 16-, and 86-fold decrease for 3-30, on ES-2, HO-8190, and K562, respectively. Therefore, it showed that b-triuoromethyl vinylsulfone along with an acetyl group on the p-position of Ar 1 was essential for the antitumor activity. Subsequently, varies different electron-withdrawing groups were introduced to Ar 2 with the structure of compound 3-27 as the structural template ( Table 3 , compounds 31-41). Unfortunately, no compound showed better proles than that of compound 3-27.
The further time courses of the proliferation inhibitions on Skov3, HO-8910, ES-2, and K562 cells of compound 3-27 were conducted with different concentrations (10 and 1 mM) for different time periods (12, 24, 36, and 48 h) . As shown in Scheme 3, the cellular growth was obviously inhibited in a dose- and time-dependent manner. All of tested cell lines were more sensitive to compound 3-27 treatment than doxorubicin. Furthermore, special attention was paid to potential cell toxicities caused by the tested compounds. The cell toxicities of several active compounds were evaluated on human bone marrow mesenchymal stem cells (hBMSCs), compared with doxorubicin (Table 4 ). Except compound 3-31, all of these tested compounds had much lower toxicities on hBMSCs. A representative example, compound 3-27 had much higher inhibition activities on tumor cells with only 1/5 toxicity on hBMSCs than doxorubicin, which indicates a potential development of such a new kind of skeleton as an alternative chemo drug.
Conclusions
In summary, we have identied several hits with a structural btrans-triuoromethyl vinylsulfone, which shows promising biological effects on antitumor with low cell toxicities, even the biological target is still unknown. The moderate electronwithdrawing groups, such as chloro, bromo, or acetyl group, on the p-position of Ar 1 and with Ar 2 unsubstituted both benet the activity. More studies of structure-activity relationship, biological mechanism, and in vivo activity are likely to be subsequently conducted on such a lead compound.
Experimental
Cell culture
Human ovarian cancer cells (ES-2, HO-8910, Skov3, and A2780), human alveolar basal epithelial cells (A549), human hepatocellular carcinoma cells (Bel-7402), human myelogenous leukemia cells (K562) and human bone marrow mesenchymal stem cell (hBMSCs) were obtained from the Type Culture Collection of Chinese Academy of Sciences (Shanghai, China). Cancer cells were maintained in RPMI-1640 supplemented with antibiotics (100 units per mL penicillin A and 100 mg mL À1 streptomycin) and 10% FBS in an atmosphere of 5% CO 2 at 37 C. hBMSCs was maintained in high glucose DMEM with 10% FBS. The medium was changed every three days. Exponentially growing cells were plated at a nal concentration of 1 Â 10 4 cells per well in 96-well plates for cell proliferation assay.
Cell viability
The cell growth inhibitory effect of tested compounds determined using the MTT assay. Aer incubation for 24 h in 96-well plates, cells were treated with various concentrations (25, 12.5, 6.25, 3.12, 1.56, 0.78, 0.39, and 0 .20 mM) of tested compounds for 48 hours, and the MTT solution (0.5 mg mL À1 ) was added. Aer 4 h of incubation at 37 C for MTT-formazan formation, the supernatant was removed and 100 mL of dimethyl sulfoxide (DMSO) was added into each well. Absorbance at 490 nm was determined spectrophotometrically by using a microplate reader (Epoch, BioTek Instruments, Inc., VT, USA). Each concentration was performed in triplicate. Antitumor activity was evaluated using IC 50 determined by non-linear regression analysis.
General experimental procedure for the synthesis of (E)-b-triuoromethyl vinylsulfones from alkyne, Togni reagent, and sodium benzenesulnate
Under nitrogen atmosphere, a mixture of alkyne 1 (0.2 mmol) and Togni reagent (0.22 mmol) in DMSO (1.0 mL) was stirred for several minutes. Then sodium benzenesulnate 2 (0.4 mmol) in DMSO (2.0 mL) was added to the solution. The mixture was stirred overnight at room temperature. Aer completion of reaction as indicated by TLC, water (10 mL) was added and the mixture was extracted by EtOAc (3 Â 10 mL). The solvent was evaporated and the residue was puried by ash column chromatography (EtOAc/n-hexane, 1 : 8) to give the desired product 3. Data of typical examples are shown below.
(E)-1-Bromo-4- (3,3,3-triuoro-1-(phenylsulfonyl) prop-1-en-1yl)benzene (E)-1-(3,3,3-Triuoro-1-(phenylsulfonyl)prop-1-en-1-yl)-4-(triuoromethyl)benzene (3) (4) . White solid, 53.5 mg, 70.4% yield, 1 H NMR (400 MHz (E)-4-(3,3,3-Triuoro-1-(phenylsulfonyl)prop-1-en-1-yl)-1,1 0biphenyl (3) (4) (5) . Pale yellow solid, 55.0 mg, 70.9% yield, 1 H NMR 
